J Stroke.
2015 Sep;17(3):229-237. 10.5853/jos.2015.17.3.229.
Patent Foramen Ovale and Stroke-Current Status
- Affiliations
-
- 1Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ohyoung.bang@samsung.com
- 2Department of Neurology, National Medical Center, Seoul, Korea.
- KMID: 2381488
- DOI: http://doi.org/10.5853/jos.2015.17.3.229
Abstract
- Patent foramen ovale (PFO) is growing in clinical interest because of a renewed focus on embolic stroke of undetermined source (ESUS), the PFO attributable fraction (the 10-point Risk of Paradoxical Embolism score), technical advances in PFO diagnosis, and the emergence of endovascular device closure as a treatment option. However, recent randomized controlled trials of the management of patients with ESUS and PFO failed to demonstrate the superiority of closure over medical treatment. The mechanisms of stroke other than paradoxical embolism may be important in patients with ESUS and PFO. This paper reviews the current understanding of the pathophysiology of stroke and therapeutic options in patients with PFO and ESUS.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Patent Foramen Ovale and Cryptogenic Stroke
- Transcatheter Closure of Patent Foramen Ovale in a Stroke Patient under the Guidance of Transesophageal Echocardiography
- CT Diagnosis of Paradoxical Embolism via a Patent Foramen Ovale in a Patient with a Pulmonary Embolism and Prominent Eustachian Valve
- Multidetector Row CT Detection of a Patent Foramen Ovale Causing Neurologic Deficits in an Adolescent: A Case Report
- A New Method for Patent Foramen Ovale Closure: Delivering Sheath Over Coronary Sinus Catheter into Left Atrium
